Top compounds associated with response to MARK1


Feature Type Standardized
Nominal ANOVA
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.24 2e-11
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.25 1e-10
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 2e-08
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.22 2e-08
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.3 2e-08
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.19 3e-08
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-08
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.19 5e-08
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.19 9e-08
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 1e-07
Download CSV